Total Payments
$708,036
2024 Payments
$88,820
Companies
67
Transactions
2,517
Medicare Patients
11,240
Medicare Billing
$1.5M
Payment Breakdown by Category
Other$526,293 (74.3%)
Travel$100,282 (14.2%)
Food & Beverage$54,300 (7.7%)
Consulting$26,831 (3.8%)
Education$269.87 (0.0%)
Gifts$59.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $520,647 | 318 | 73.5% |
| Travel and Lodging | $100,282 | 164 | 14.2% |
| Food and Beverage | $54,300 | 1,983 | 7.7% |
| Consulting Fee | $26,831 | 18 | 3.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $3,763 | 7 | 0.5% |
| Honoraria | $1,884 | 2 | 0.3% |
| Education | $269.87 | 24 | 0.0% |
| Gift | $59.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $255,639 | 434 | $0 (2024) |
| Lilly USA, LLC | $113,546 | 376 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $93,169 | 239 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $71,599 | 141 | $0 (2024) |
| Amarin Pharma Inc. | $53,063 | 88 | $0 (2022) |
| Abbott Laboratories | $34,337 | 220 | $0 (2024) |
| Merck Sharp & Dohme LLC | $28,892 | 105 | $0 (2023) |
| Ascensia Diabetes Care Us Inc. | $11,131 | 25 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $8,213 | 36 | $0 (2024) |
| Senseonics, Incorporated | $5,556 | 21 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $88,820 | 320 | Lilly USA, LLC ($54,537) |
| 2023 | $42,467 | 265 | Abbott Laboratories ($9,854) |
| 2022 | $71,566 | 311 | Novo Nordisk Inc ($51,381) |
| 2021 | $41,922 | 247 | Novo Nordisk Inc ($17,634) |
| 2020 | $27,394 | 154 | Novo Nordisk Inc ($12,606) |
| 2019 | $112,952 | 346 | Novo Nordisk Inc ($31,308) |
| 2018 | $148,730 | 395 | Novo Nordisk Inc ($71,611) |
| 2017 | $174,184 | 479 | Novo Nordisk Inc ($65,074) |
All Payment Transactions
2,517 individual payment records from CMS Open Payments — Page 1 of 101
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $131.00 | General |
| Category: Automated insulin delivery system | ||||||
| 12/30/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $81.75 | General |
| Category: Automated insulin delivery system | ||||||
| 12/30/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: Automated insulin delivery system | ||||||
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Diabetes Care | ||||||
| 12/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Diabetes Care | ||||||
| 12/16/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Obesity | ||||||
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $2.29 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $1.93 | General |
| Category: Diabetes Care | ||||||
| 12/11/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/11/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: Diabetes Care | ||||||
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: Diabetes Care | ||||||
| 12/10/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: Automated insulin delivery system | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $125.88 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Diabetes Care | ||||||
| 12/03/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $130.63 | General |
| Category: Automated insulin delivery system | ||||||
| 12/03/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: Durable Pump | ||||||
| 11/26/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: Diabetes Care | ||||||
| 11/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $1,793.40 | General |
| Category: Diabetes Care | ||||||
| 11/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: Cardiology | ||||||
| 11/19/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,968 | 6,270 | $769,790 | $273,262 |
| 2022 | 24 | 2,273 | 11,787 | $873,430 | $291,703 |
| 2021 | 22 | 3,492 | 30,159 | $1.2M | $531,112 |
| 2020 | 24 | 3,507 | 24,941 | $848,961 | $359,908 |
Total Patients
11,240
Total Services
73,157
Medicare Billing
$1.5M
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 198 | 1,588 | $184,704 | $73,595 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 348 | 598 | $153,048 | $51,092 | 33.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 210 | 1,370 | $127,396 | $48,522 | 38.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 207 | 1,351 | $131,410 | $46,267 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 191 | 288 | $53,400 | $17,240 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 147 | 147 | $51,450 | $16,302 | 31.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 87 | 91 | $22,750 | $6,730 | 29.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 88 | 149 | $9,850 | $3,736 | 37.9% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 17 | 19 | $4,484 | $1,851 | 41.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 143 | 186 | $6,510 | $1,761 | 27.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $4,112 | $1,466 | 35.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $4,747 | $1,273 | 26.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 188 | 323 | $6,460 | $1,031 | 16.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 59 | 61 | $3,269 | $789.88 | 24.2% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2023 | 19 | 19 | $2,565 | $600.80 | 23.4% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 11 | 16 | $1,200 | $423.78 | 35.3% |
| J0834 | Injection, cosyntropin, 0.25 mg | Office | 2023 | 11 | 17 | $2,210 | $371.43 | 16.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 25 | $225.00 | $210.00 | 93.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 264 | 1,913 | $224,450 | $91,457 | 40.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 317 | 1,454 | $152,312 | $53,089 | 34.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 300 | 1,338 | $196,912 | $51,074 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 312 | 493 | $127,088 | $42,316 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 146 | 146 | $51,100 | $17,095 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 160 | 220 | $40,796 | $12,409 | 30.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 99 | 100 | $25,000 | $7,306 | 29.2% |
About Dr. Bantwal Baliga, M.D
Dr. Bantwal Baliga, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Opelika, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992847669.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bantwal Baliga, M.D has received a total of $708,036 in payments from pharmaceutical and medical device companies, with $88,820 received in 2024. These payments were reported across 2,517 transactions from 67 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($520,647).
As a Medicare-enrolled provider, Baliga has provided services to 11,240 Medicare beneficiaries, totaling 73,157 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Opelika, AL
- Active Since 02/12/2007
- Last Updated 07/28/2012
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992847669
Products in Payments
- JARDIANCE (Drug) $109,132
- FARXIGA (Drug) $84,939
- Ozempic (Drug) $64,613
- Tresiba (Drug) $53,769
- Vascepa (Drug) $53,063
- Rybelsus (Drug) $48,264
- Victoza (Drug) $42,231
- ZEPBOUND (Drug) $33,985
- BASAGLAR (Drug) $25,136
- STEGLATRO (Drug) $24,800
- FREESTYLE LIBRE 3 (Device) $23,455
- RYBELSUS (Drug) $16,910
- t-slim insulin pump (Device) $7,917
- BYDUREON (Drug) $7,785
- Xultophy 100/3.6 (Drug) $7,697
- Eversense (Device) $5,556
- BIGFOOT UNITY DIABETES MANAGEMENT SYSTEM (Device) $5,081
- V-GO (Device) $4,604
- Korlym (Drug) $3,632
- EVERSENSE E3 SENSOR KIT - RETAIL (Device) $2,741
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.